Aurinia Pharmaceuticals Inc. (AUPH)
NASDAQ: AUPH · IEX Real-Time Price · USD
5.42
+0.04 (0.74%)
At close: May 31, 2024, 4:00 PM
5.52
+0.10 (1.85%)
After-hours: May 31, 2024, 6:53 PM EDT
Aurinia Pharmaceuticals Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for AUPH stock have an average target of 10.33, with a low estimate of 8.00 and a high estimate of 13. The average target predicts an increase of 90.59% from the current stock price of 5.42.
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 1, 2024.
Analyst Ratings
The average analyst rating for AUPH stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 3 | 3 | 2 | 2 | 2 | 2 |
| Hold | 1 | 1 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $13 | Strong Buy | Reiterates | $13 | +139.85% | Mar 1, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $12 → $10 | Buy | Maintains | $12 → $10 | +84.50% | Feb 23, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $15 → $13 | Strong Buy | Maintains | $15 → $13 | +139.85% | Feb 22, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $13 → $8 | Buy | Maintains | $13 → $8 | +47.60% | Feb 16, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +176.75% | Sep 22, 2023 |
Financial Forecast
Revenue This Year
232.86M
from 175.51M
Increased by 32.67%
Revenue Next Year
287.95M
from 232.86M
Increased by 23.66%
EPS This Year
0.07
from -0.54
EPS Next Year
0.48
from 0.07
Increased by 576.19%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 248.8M | 334.4M | 429.9M | 535.1M | 643.7M |
| Avg | 232.9M | 288.0M | 356.5M | 423.4M | 470.1M |
| Low | 212.7M | 245.0M | 288.1M | 323.4M | 343.0M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 41.7% | 43.6% | 49.3% | 50.1% | 52.1% |
| Avg | 32.7% | 23.7% | 23.8% | 18.7% | 11.0% |
| Low | 21.2% | 5.2% | 0.1% | -9.3% | -19.0% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 0.21 | 0.84 | 1.33 | 1.91 | 2.12 |
| Avg | 0.07 | 0.48 | 0.90 | 1.22 | 1.36 |
| Low | -0.20 | 0.22 | 0.43 | 0.34 | 0.65 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | 1,076.5% | 176.2% | 111.7% | 74.0% |
| Avg | - | 576.2% | 87.0% | 35.0% | 11.9% |
| Low | - | 202.0% | -10.7% | -62.0% | -46.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.